Five-Year Follow-up after Mesenchymal Stromal Cell-based Treatment of Severe Acute Respiratory Distress Syndrome

Am J Respir Crit Care Med. 2020 Oct 1;202(7):1051-1055. doi: 10.1164/rccm.202003-0544LE.

Authors

Oscar E Simonson^{1

2}, Elisabeth Ståhle^{1

2}, Tomas Hansen^{1

2}, Johan O Wedin^{1

2}, Anders Larsson^{1

2}, Mattias Mattsson^{1

2}, Pavel Volchkov³, Katarina Le Blanc^{4

5}, Sergey Rodin^{2

5}, Karl-Henrik Grinnemo^{1

2

5}

Affiliations

¹ Uppsala University Hospital, Uppsala, Sweden.
² Uppsala University, Uppsala, Sweden.
³ Moscow Institute of Physics and Technology, Dolgoprudny, Russia.
⁴ Karolinska University Hospital, Stockholm, Sweden and.
⁵ Karolinska Institutet, Stockholm, Sweden.

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Adult
Extracorporeal Membrane Oxygenation*
Follow-Up Studies
Forced Expiratory Volume
Health Status
Humans
Lung / diagnostic imaging*
Lung / physiopathology
Male
Mental Health
Mesenchymal Stem Cell Transplantation / methods*
Middle Aged
Physical Functional Performance
Quality of Life
Respiration, Artificial*
Respiratory Distress Syndrome / therapy*
Return to Work
Severity of Illness Index
Walk Test